The QualityStocks Daily Wednesday, January 5th, 2022

Today's Top 3 Investment Newsletters

QualityStocks(LIXT) $2.2100 +63.70%

MarketClub Analysis(MYNZ) $15.2100 +46.39%

BioMedWire(CNSP) $1.0500 +31.36%

The QualityStocks Daily Stock List

Lixte Biotechnology Holdings, Inc. (LIXT)

QualityStocks, TopPennyStockMovers, Wall Street Mover, Real Pennies, PoliticsAndMyPortfolio.com, PoliticsAndMyPortfolio, MarketClub Analysis and INO Market Report reported earlier on Lixte Biotechnology Holdings, Inc. (LIXT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily centered on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers. A clinical-stage pharmaceutical company, Lixte Biotechnology Holdings is headquartered in East Setauket, New York. The Company’s shares trade on the OTCQB.

Lixte has identified molecular signaling pathways altered in disease states. The Company has also designed compounds that can safely target them in animal models. Lixte’s present drug portfolio includes inhibitors of serine/threonine protein phosphatases critical to cell division and DNA damage repair and inhibitors of protein deacetylases, which regulate pathways of gene expression and protein degradation.

The phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general and radiation therapy. This makes them potentially useful for the treatment of numerous cancers in combination with existing standard chemotherapy regimens and with the developing targeted cytotoxic therapies of personalized cancer medicine.

Additionally, in a pre-clinical study done with scientists under collaborative research and development (R&D) agreements at the National Institutes of Health, Lixte Biotechnology’s lead compound, LB-100, enhanced the antitumor activity of a major immune checkpoint inhibitor. Therefore, this raises the possibility that in addition to improving the efficacy of standard cytotoxic anti-cancer drugs, Lixte’s phosphatase inhibitors may potentiate immunotherapy regimens (Ho 2017).

Previously, Lixte Biotechnology Holdings noted that investigators at the National Cancer Institute (NCI) and National Institute of Neurological Disorders and Stroke (NINDS) reported that the Company’s lead clinical compound, LB-100, enhanced pharmacological immunotherapy of intracranial brain tumors in immune-competent mice. This includes 25 percent complete regression and immunity to tumor rechallenge (Journal of Neuro-oncology, on-line April 27, 2020).

Dr. John S. Kovach, Chief Executive Officer of Lixte Biotechnology and one of the authors of the article, said, “The new article reports that the combination of LB-100 plus a PD1 blocker shrank the GBM cancers implanted in the brain, including elimination of tumor and development of immunity to re-challenge with the same tumor in 25% of the animals. These investigators had previously shown that LB-100 enhances the anti-tumor activity of a PD1 blocker in a mouse model of colon cancer but this is the first report that inhibition of PP2A activity improves the efficacy of PD1 blockade in a model of GBM.”

Lixte Biotechnology Holdings, Inc. (LIXT), closed Wednesday's trading session at $2.21, up 63.7037%, on 119,872,796 volume with 303,190 trades. The average volume for the last 3 months is 119.806M and the stock's 52-week low/high is $1.1076/$7.19.

Halberd (HALB)

PennyStocks24, Stock Twiter, Pumps and Dumps, WallstreetSurfers, ElitePennies, Ironman Stock, Investor News Source, WiseAlerts, Greenbackers, QualityStocks, AskSlapper, TheMicrocapNews, TradeThesePicks, MajorPennyStocks, AimHighProfits, InvestorPlace, AddictivePennyStocks, BUYINS.NET, Otcstockexchange, Penny Dreamers, Actual Gains, PennyStockRumors.net, PennyStockSpy, PricelessPennyStocks, Stock Legends, Stocktwiter, TryBestPennyStocks.biz, Whisper from Wall Street and PennyDoctor reported earlier on Halberd (HALB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Halberd Corporation (OTC: HALB) is a biotechnology firm that is engaged in the research and development of devices and antibodies for the treatment, detection and prevention of various ailments, through clinical, hospital and lab trials.

The company is headquartered in Jackson Center, Pennsylvania and was founded in 2009, on January 26th. It develops pharmaceutical products for the treatment of ailments like cancers, atherosclerosis, blood sepsis, Alzheimer’s disease, clinical depression, multiple sclerosis, post-traumatic stress disorder, traumatic brain injury and amyotrophic lateral sclerosis.

It provides extracorporeal treatment that can be applied to different neurologic and blood-borne ailments, which include the coronavirus as well as other viruses. It has obtained exclusive licenses for 2 patents and has 4 provisional patent applications for these treatments. It also operates as a manufacturer and seller of unmanned aircrafts, which are intended for both governmental and private use in industries like border/coastal surveillance, agriculture, forestry, meteorological, municipal, oil and gas and military industries.

Two of the company’s monoclonal antibodies that are yet to have their patents approved have showed strong neutralizing capabilities and an affinity against 3 of the identified coronavirus mutations. The antibodies have been successfully tested against the Q493K, P499T and Q498Y SARS-CoV-2 variants and the company plans to begin mouse testing in order to confirm the laboratory tests.

The firm’s antibodies may be the solution to this disease’s mutations and may be used to produce a vaccine that protects against the original strain as well as the mutations, which will not only address a need that is yet to be met but also extend the company’s reach.

Halberd (HALB), closed Wednesday's trading session at $0.02655, up 56.1765%, on 76,416,574 volume with 2,502 trades. The average volume for the last 3 months is 76.417M and the stock's 52-week low/high is $0.012/$0.109.

Good Gaming (GMER)

Penny Stock Mobsters, WallstreetSurfers, SizzlingStockPicks, QualityStocks, POSstocks, OnPointStockAlert, Stockgoodies, PennyPickAlerts, Fortune Stock Alerts, Wall Street Mover, ProTrader, PoliticsAndMyPortfolio, PennyStock Tweets and PennyDoctor reported earlier on Good Gaming (GMER), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Good Gaming Inc. (OTC: GMER) is a firm that is engaged in the provision of online gaming platform services to active gamers.

The firm has its headquarters in Kennett Square, Pennsylvania and was incorporated in 2008 on November 3rd. It operates as part of the advertising and marketing services industry, under the technology sector in the software and tech services industry, under the software sub-industry.

The enterprise uses its technology platform to provide vendors and publishers an approach to gaming interactions. Its platform enables integration into other existing systems and the integration of 3rd party applications. Additionally, the framework enables guilds/teams/clans to interact which each other, communicate and add functionality over a period of time to include running their own tournaments leveraging the online communities’ viral nature.

The company is an online destination and leading tournament gaming platform that targets more than 250 million amateur gamers globally who would like to compete at the college or high school level. It offers content aggregation, e-sports venues and tournament hosting. This is in addition to engaging in the development of Minecraft servers. The company is also involved in the cryptocurrency business through its Crypto Strategies Group and provides articles, videos and blogs authored by world-renowned professional gamers.

The firm is expanding its business operations to include blockchain digital assets called NFTs (non-fungible tokens). It recently announced that it was planning to launch an online game that will allow gamers to profit from the firm’s cryptocurrency, known as GOO. This will extend its consumer reach and increase investments into the firm.

Good Gaming (GMER), closed Wednesday's trading session at $0.09, up 38.4615%, on 5,765,378 volume with 715 trades. The average volume for the last 3 months is 5.753M and the stock's 52-week low/high is $0.0163/$0.75.

BTCS Inc. (BTCS)

RedChip, QualityStocks, Stock Commander, HotStockProfits, PoliticsAndMyPortfolio, Value Penny Stocks, TheMicrocapNews, Wall Street Mover, AddictivePennyStocks, AllPennyStocks, Bullseyestox.com, Fortune Stock Alerts, Market Authority, Money Morning, Penny Stock Circle, PennyPro, PennyStockRumors.net, 1-2-3 Stock Alerts, PricelessPenny, SmallCapVoice, Stock Beast, StockMarketQuote.us, StockMister, TradersPro and PennyStocks Forever reported earlier on BTCS Inc. (BTCS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BTCS Inc. (OTCQB: BTCS) is focused on digital currency ecosystems and blockchain technologies and is also engaged in the sale of different types of merchandise for virtual currencies.

The firm has its headquarters in Silver Spring, Maryland and was incorporated in 2008 by Michal Handerhan and Timothy Sidie. Prior to its name change in July 2015, the firm was known as Bitcoin Shop Inc. It operates as part of the computer software industry.

The enterprise is working on building a digital currency platform, with the objective being to allow users to engage in the digital currency ecosystem via one access point. It plans to utilize its e-commerce platform for a broader digital currency platform. In addition, it’s planning on acquiring digital assets to offer investors with indirect ownership of ether and bitcoin via open market purchases.

The company manages a beta e-commerce marketplace that has designed a BTCS wallet and a digital currency storage solution that accepts various digital currencies. BTCS Inc. also provides management services for digital currency wallets and digital currency ecosystems as well as secured information, transaction verification and up-to-date inventory services. Its online marketplace allows consumers to buy commodities using digital currencies like bitcoin.

The firm recently released their first quarter results for 2021, having launched its ethereum 2.0 blockchain staking operation in the same period. Its blockchain infrastructure operations which enable it to secure proof-of-stake blockchains represent a high profit margin component for its business model. The firm is planning to continue the expansion of its proof-of-stake operations by operating more nodes on ethereum’s beacon chain, which will bring in more revenue.

BTCS Inc. (BTCS), closed Wednesday's trading session at $4.36, up 43.8944%, on 65,004,237 volume with 211,140 trades. The average volume for the last 3 months is 65.186M and the stock's 52-week low/high is $1.947/$32.40.

Alpha Pro Tech (APT)

Wall Street Resources, MarketClub Analysis, Schaeffer's, TradersPro, StockMarketWatch, BUYINS.NET, InvestorPlace, StocksEarning, Daily Trade Alert, MarketBeat, SmarTrend Newsletters, Trades Of The Day, QualityStocks, AllPennyStocks, Marketbeat.com, StreetInsider, Wall St Insider Stocks, The Street, FeedBlitz, Greenbackers, Hit and Run Candle Sticks, The Online Investor, InvestorsUnderground, Jason Bond, Rick Saddler, The Best Newsletters, Stock Research Newsletter, MarketClub, NYC Marketing Inc, Oakshire Financial, StockOodles, Wealth Daily, SmallCapInvestor, SmallCapVoice and Market FN reported earlier on Alpha Pro Tech (APT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alpha Pro Tech, Ltd (NYSE American: APT) (FRA: APL) is focused on the development, manufacture and marketing of various infection control, building supply and disposable protective apparel products.

The firm has its headquarters in Markham, Canada and was incorporated in 1983. The firm serves consumers around the globe, with a focus on the United States and Canada.

The company operates through the building supply and disposable protective apparel segments. The former segment comprises of a line of construction supply weatherization products, which include synthetic roof underlayment and house wrap, among other woven material. On the other hand, the latter segment includes various styles of disposable products, like frocks, lab coats, hoods, shields, face masks, coveralls, gowns, bouffant caps and shoe covers, among other products. The company generates the majority of its revenue from the sale of its products in the United States.

The enterprise’s products are used in healthcare facilities like dental offices, laboratories and hospitals; building and re-roofing sites; industrial safety manufacturing environments; clean rooms; pharmaceutical markets; food service markets; and pet markets. It markets its products under private labels as well as under the Alpha Pro Tech brand. The enterprise distributes its products through its sales and marketing force as well as via a network of distributors, purchasing groups and independent sales representatives.

The company is focused on increased the production capacity of its building supply segment, having seen significant growth in sales from the products under this segment in 2021. This will be good for its growth and encourage more investments into the company.

Alpha Pro Tech (APT), closed Wednesday's trading session at $5.92, off by 0.837521%, on 501,049 volume with 2,591 trades. The average volume for the last 3 months is 491,086 and the stock's 52-week low/high is $4.91/$20.54.

Auto Trader Group (ATDRY)

MarketBeat, Trades Of The Day, Daily Trade Alert, QualityStocks and StreetInsider reported earlier on Auto Trader Group (ATDRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Auto Trader Group Plc (OTC: ATDRY) (FRA: 2UA0) (LON: AUTO) is an automotive advertising firm that operates in the digital automotive marketplace.

The firm has its headquarters in Manchester, the United Kingdom and was incorporated in 1977 by Robert John Madejski. The firm serves consumers in Ireland and the United Kingdom.

The company operates through the manufacturer and agency, customer services and trade segments. The agency segment involves manufacturers and their advertising agencies placing display advertising on the firm’s websites. The customer services segment comprises of third-party partners offering services to consumers associated with their motoring needs, like loan finance and insurance, as well as private sellers for vehicle advertisements. On the other hand, the trade segment involves the revenue generated from home trader and retailer customers who use the firm’s products and advertise their vehicles on the firm’s site. The company generates most of its revenue from advertising.

The enterprise offers various products and services to consumers, including free car valuations. It also provides a finance search tool on its site, which enables customers to search by monthly budget. In addition to this, it sells trucks, caravans, motor homes, vans, bikes, cars and farm machinery. It mainly serves logistics companies, home traders and retailers.

The company reinvests a significant amount of its profits at a high rate of return, which has caused it to see a considerable amount of growth in its earnings. Analysts estimate that the company’s earnings will gain momentum soon, which will be good for its shareholders.

Auto Trader Group (ATDRY), closed Wednesday's trading session at $2.485, off by 0.798403%, on 132,360 volume with 228 trades. The average volume for the last 3 months is 132,360 and the stock's 52-week low/high is $1.91/$2.55.

Rainmaker Worldwide (RAKR)

QualityStocks, StockStreetWire, StockRockandRoll, Profitable Trader Authority, PennyStockProphet, PennyStockLocks, Penny Stock 101, Penny Pick Finders, OTCtipReporter, MicroCapDaily, HotOTC and Buzz Stocks reported earlier on Rainmaker Worldwide (RAKR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rainmaker Worldwide Inc. (OTC: RAKR) is a clean technology firm that is focused on the development, sale and commercialization of patented water technologies which provide drinking water.

The firm has its headquarters in Peterborough, Canada and was incorporated in 2006, on January 1st. The firm serves consumers around the globe.

The company provides environmental-friendly and innovative water solutions to communities and businesses which face water scarcity.

The enterprise develops air-to-water and water-to-water energy-efficient, fresh water-producing technologies. These technologies are both solar and wind powered and leave no carbon traces. They can be deployed to any place that needs drinking water quickly and easily. Its air-to-water technology harvests fresh water from humidity in the atmosphere, making it useful in remote vacation houses, temporary vacation homes and islands, particularly for rural and island communities with limited fresh water supplies or people living in hot conditions. The technology has no risk of water-borne illnesses. On the other hand, the water-to-water technology produces clean water from contaminated water sources, brackish water or seawater. This technology is ideal for corporations seeking energy-efficient technology to clean and possibly reuse waste water. The enterprise’s other products include a wind powered product dubbed AW-W100; and a solar powered product known as WW-SO50. It serves communities as well as the global beverage, industrial, commercial and agriculture industries.

The firm is set to up-list to the OTCQB, bringing them one step closer to gaining wider access to efficient capital and extending its reach. This development will positively influence investments into the firm, which will be good for its growth.

Rainmaker Worldwide (RAKR), closed Wednesday's trading session at $0.0171, off by 4.7354%, on 257,295 volume with 23 trades. The average volume for the last 3 months is 257,295 and the stock's 52-week low/high is $0.0149/$0.115.

American Battery Technology (ABML)

QualityStocks, InvestorPlace, Trades Of The Day, TradersPro and MarketBeat reported earlier on American Battery Technology (ABML), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Battery Technology Co. (OTCQB: ABML) is a battery metal firm that is focused on exploring for, mining, extracting and recycling battery metals.

The firm has its headquarters in Reno, Nevada and was incorporated in 2011, on October 6th. Prior to its name change in October 2021, the firm was known as American Battery Metals Corporation. It operates as part of the motor vehicle and motor vehicle parts and supplies merchant wholesalers’ industry. The firm has three companies in its corporate family and serves consumers around the globe, with a focus on the United States.

The company produces low-cost battery metals and evaluates as well as develops lithium extraction processes for the sustainable and cost-effective recovery of battery-grade lithium products from claystone, brine and hardrock, among other sources. It also commercializes internally developed integrated processes for Li-ion battery recycling, and for battery metal recovery.

The enterprise uses its clean technology platform to develop batteries that are used to power consumer electronics and tools, grid storage applications and electric cars. It owns 644 placer mining claims on roughly 12,800 acres in the Western Nevada Basin, which is situated in Nye County’s Railroad Valley. It also owns a 120-acre private property with water rights, near Railroad Valley in the town of Currant.

The company recently announced that it had acquired additional claims, which will enable it to scale-up the commercial operations of its low-cost manufacturing lithium process. This move will be good for the company’s revenues as well as its long-term growth.

American Battery Technology (ABML), closed Wednesday's trading session at $0.985, off by 4.3689%, on 3,938,029 volume with 1,904 trades. The average volume for the last 3 months is 3.938M and the stock's 52-week low/high is $0.702/$4.90.

Atlantic Power & Infrastructure (AWSL)

Penny Stock Chaser, GreenBubbleStocks, MypennystockZ, HyperGrowthStock, Bull Market Newsletter, CoolPennyStocks, Damn Good Penny Picks, HotOTC, Penny Picks, Penny Stock Newsletter, PREPUMP STOCKS, Stock Rich, PennyStockScholar, Wallstreetbuzz, Whisper from Wall Street, OTCtipReporter, BestDamnPennyStocks, WallstreetsHotteststocks, Wall Street News Alert, Equity Observer, TheNextBigTrade, StockRunway, StockEgg, Jet-Life Penny Stocks, Penny Invest, Morning Stock Picks, QualityStocks, Otcstockexchange, AlphaTrade, smartOTC, SmallCapGrowth, Real Pennies, Profitable Trader Authority and MajorPennyStocks reported earlier on Atlantic Power & Infrastructure (AWSL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Atlantic Power & Infrastructure Corp (OTC: AWSL) is a renewable energy development firm that is focused on pursuing, developing, financing, owning and operating photovoltaic solar and wind energy projects.

The firm has its headquarters in Largo, Florida and was incorporated in 2001. Prior to its name change in April 2021, the firm was known as Atlantic Wind & Solar Inc. Before this, it changed its name in 2019, from K.B. Industries Inc. It serves consumers around the globe, with a focus on the United States, Canada and Europe.

The company is focused on solving the global environmental waste crisis while producing energy, fertilizer and other beneficial sources of income. It combines experience and technology to solve the toughest infrastructure and environmental issues. By repurposing destructive waste into eco-friendly commodities, the company manufactures smarter materials utilized in earth reclamation projects, renewable energy, infrastructure, air and water purification, among other critical industries.

The enterprise develops eco-friendly infrastructure products and renewable energy, helping ensure a healthier, cleaner and more energy-secure future for the Earth. It also converts biomass agricultural, food, yard and war sewage as well as municipal solid waste into energy pellets. This is in addition to developing flexible porous paving products and solutions. For instance, it uses soil-stabilization technology to reduce erosion and improve dust control.

The firm, which offers sustainable environmentally beneficial technologies, is focused on expanding its full range of technologies via direct involvement in all international operations. This should bring about greater market growth internationally, which will be good for the firm’s revenues.

Atlantic Power & Infrastructure (AWSL), closed Wednesday's trading session at $0.04565, up 1.1074%, on 111,260 volume with 9 trades. The average volume for the last 3 months is 111,260 and the stock's 52-week low/high is $0.04/$0.49.

Mondelez International Inc. (MDLZ)

MarketClub Analysis, Kiplinger Today, The Street, InvestorPlace, Schaeffer's, StreetInsider, StocksEarning, INO.com Market Report, MarketBeat, Louis Navellier, Daily Trade Alert, The Online Investor, StreetAuthority Daily, Market Intelligence Center Alert, Market FN, Barchart, The Street Report, The Best Newsletters, Zacks, TopStockAnalysts, Marketbeat.com, Trades Of The Day, Investopedia, Top Pros' Top Picks, Daily Profit, Investors Alley, MarketWatch, The Wealth Report, Uncommon Wisdom, CNBC Breaking News, Money Morning, Wyatt Investment Research, AllPennyStocks, Stock Research Newsletter, Trading Concepts, Shah's Insights & Indictments, Todd Horwitz, Street Insider, Daily Dividends, Darwin Investing Network, SmallCapVoice, The Wall Street Transcript, YOLOTraderAlerts, Profit Confidential, Insider Wealth Alert, Inside Investing Daily, The Stock Dork, INO Market Report, Hit and Run Candle Sticks, Greenbackers, Trader Prep, Navellier Growth, Investment Contrarians, Wallstreet Journal, Wealth Daily, Wealth Empire, BUYINS.NET, WStreet Market Commentary, Average Joe Options, Early Bird, Stock Tips Network, Money and Markets, MarketDeal, Profits Run, ResearchOTC, Rick Saddler, MarketArmor.com, Investing Signal, Market Intelligence Center, Investiv, StockEarnings, Stocks To Watch, The FrontPageStocks, The Growth Stock Wire, InvestmentHouse, Investment U, 1-2-3 Stock Alerts and SECFilings.com News reported earlier on Mondelez International Inc. (MDLZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Shares of Mondelez International Inc. (NASDAQ:MDLZ) traded at a new 52-week high today of $67.23. Approximately 652,000 shares have changed hands today, as compared to an average 30-day volume of 7 million shares.

Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (48% of sales), chocolate (31%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.

Based on a current price of $67.23, Mondelez International Inc. is currently 21.8% above its average consensus analyst price target of $52.58.

In the past 52 weeks, Mondelez International Inc. share prices are bracketed by a low of $52.91 and a high of $67.23 and is now at $67.23, 27% above that low price.

Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

Mondelez International Inc. (MDLZ), closed Wednesday's trading session at $67.41, up 1.4447%, on 10,715,871 volume with 95,250 trades. The average volume for the last 3 months is 10.714M and the stock's 52-week low/high is $52.91/$67.96.

CRA International, Inc. (CRAI)

SmarTrend Newsletters, Zacks, MarketBeat, Daily Markets, Trading Markets, Top Pros' Top Picks, StreetInsider, QualityStocks, Marketbeat.com, Market Wrap Daily, Investing Lab, Greenbackers, Darwin Investing Network and Barchart reported earlier on CRA International, Inc. (CRAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Corporate Update

CRA International (NASDAQ: CRAI) was featured in a company-sponsored research note published by Sidoti & Company, LLC. The headline of the note reads, “Historic Global M&A Activity In 2021 And Positive Order Trends In Multiple Practice Areas Support Our 2021-2023 EPS CAGR Of Over 20%; Strong Free Cash Flow Supports Our $135 Price Target.”

Click here to access the full report.

About CRA International, Inc.

Charles River Associates(R) is a leading global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Please visit www.crai.com.

CRA International, Inc. (CRAI), closed Wednesday's trading session at $91.23, off by 3.2658%, on 26,633 volume with 872 trades. The average volume for the last 3 months is 26,414 and the stock's 52-week low/high is $49.43/$116.71.

Revelstone Capital Acquisition Corp. (RCACU)

We reported earlier on Revelstone Capital Acquisition Corp. (RCACU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Revelstone Capital (NASDAQ: RCACU) has closed its initial public offering of 15,000,000 units, each at a price of $10.00. The units began trading on the Nasdaq Global Market under the ticker symbol RCACU on Dec. 17, 2021. According to the update, each unit consists of one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant entitling the holder to purchase one share of common stock, each at a price of $11.50. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be listed on the Nasdaq under the symbols RCAC and RCACW. The underwriters were granted a 45-day option to purchase up to an additional 2,250,000 units from the company at the initial public offering price to cover over-allotments, if any. Roth Capital Partners acted as joint book-running manager for the offering.

To view the full press release, visit https://ibn.fm/FH4Ck

About Revelstone Capital Acquisition Corp.

Revelstone Capital is a blank check company, also commonly referred to as a special purpose acquisition company, or “SPAC,” formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is the company’s intention to pursue prospective targets in the consumer, media and/or technology markets with a focus on the active consumer landscape. For more information about the company, visit www.Revelstonecapital.com.

Revelstone Capital Acquisition Corp. (RCACU), closed Wednesday's trading session at $9.95, up 0.100604%, on 6,902 volume with 61 trades. The average volume for the last 3 months is 6,902 and the stock's 52-week low/high is $9.86/$10.09.

The QualityStocks Company Corner

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

  • Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth
  • Zacks have also upped their fiscal year 2022 revenue forecast to $42.52 million, implying +35% YoY growth
  • SRAX’s implied results look even more impressive given that it will no longer be consolidating the financials of key subsidiary, BIGtoken, following the latter company’s merger with BritePool, Inc
  • SRAX’s future growth trajectory is set to be dictated by investor intelligence platform, Sequire, having recently recorded its twelfth consecutive quarter of revenue growth

SRAX (NASDAQ: SRAX) a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has seen its financial performance go from strength to strength over the past year. SRAX recently reported its third quarter results on November 15th, 2021, revealing third quarter revenues of $8.3 million, a figure which was up 219% year-over-year and 8% on a quarter-over-quarter basis. Zacks Investment Research, an American independent research and investment content advisory, has recently published its forecast for the upcoming quarter, projecting SRAX to report $10.05 million in sales for the current fiscal quarter. SRAX reported sales of $4.52 million over the same quarter last year, which would imply a theoretical year over year growth rate of 122.3%. SRAX is expected to publish its fourth quarter results on Monday, April 4th, 2022 (https://ibn.fm/HnE2o). SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has scheduled several industry-specific events for 2022. The company has announced its initial schedule for 2022 conferences. The company will hold its first event — the Sequire Metals & Mining Conference — on Jan. 27, 2022; the event is slated to run from 9 a.m. to 5 p.m. ET. In making the announcement, SRAX noted that it has expanded the event to a full day based on significant increase in interest and activity in the mining and electric vehicle industries. The conference will cover topics related to sector possibilities and opportunities, as well as the latest industry news. The company also announced six other events, scheduled throughout the year and covering sectors as varied as cannabis, cryptocurrency and semiconductors to fintech and medical technology. According to the announcement, Sequire is comprised of a network of millions of influential, forward-thinking shareholders, and the conference series is one of several ways the company offers value to its investor community. “We learned so much hosting last year's conferences,” said SRAX vice president of community and events Morgan Fogg in the press release. “This year, we are looking forward to applying those learnings and expanding through partnerships, interesting content and industries we haven't yet hosted to provide a truly unique virtual conference experience.” To view the full press release, visit https://ibn.fm/GCmDg

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $4.26, up 2.1583%, on 131,190 volume with 1,126 trades. The average volume for the last 3 months is 131,190 and the stock's 52-week low/high is $2.90/$7.29.

Recent News

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC)

The QualityStocks Daily Newsletter would like to spotlight AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC).

The German pharmaceutical firm that worked with Pfizer in 2020 to develop the first coronavirus vaccine is now developing a new vaccine that harnesses the same mRNA technology it used to create an mRNA cancer vaccine. The firm, BioNTech, is currently conducting a phase 2 clinical trial for the experimental vaccine, which involves participants with cancer. BioNTech was founded more than a decade ago, with its CEO, Dr. Uğur Şahin, revealing that the company’s objective is to develop cancer therapies. The company isn’t the only one focused on developing mRNA vaccines for various indications, as the technology is said to have the potential to treat or maybe even cure chronic ailments. With next-gen cancer diagnostics being developed by entities such as AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) and the research community searching for new treatment approaches, a time may come when cancer’s toll on humanity dwindles considerably.

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) is a biotechnology company focused on early cancer screening and detection. The company develops, distributes and deploys accessible early disease detection devices with an aim of changing the way people approach cancer screening. AnPac Bio-Medical is a highly innovative company and an early thought leader and developer of multi-cancer screening technology, which is gaining significant acceptance.

AnPac Bio-Medical has clinical laboratories in the United States and China, with 142 issued patents as of March 31, 2021. Its corporate headquarters is located in Shanghai, China, while its U.S. headquarters is situated in Philadelphia, Pennsylvania. The company operates two certified clinical laboratories in China and one CLIA registered clinical laboratory in the United States.

Cancer Differentiation Analysis (CDA)

Cancer Differentiation Analysis (CDA) is AnPac Bio-Medical’s approach to detecting cancer and pre-cancerous diseases. CDA uses the natural biophysical properties of blood and cellular proteins to discover cancerous environments before the tumors even form.

Most liquid-based cancer screening and detection technologies focus on biochemical signals, like conventional biomarkers and genomic signals, such as ct-DNAs and CTCs (circulating tumor cells in the blood). These typically only determine whether or not cancer has occurred at a fixed point in time.

CDA technology combines an assessment of existing biomarkers with the biophysical properties and cellular proteins that signal the lead-up to serious health conditions and cancer. It is also used to pinpoint where cancer is most likely located and predict where the risk is highest in the future – all through a standard blood test, at a competitive price point.

AnPac Bio-Medical’s CDA is powered by a database of over 200,000 samples and cases and serves as a new way to approach disease and cancer screening. The device uses an integrated system of sensors to detect several biophysical signals at the cellular, protein and molecular levels. CDA leverages a proprietary algorithm to synthesize the data, effectively generating a personalized risk assessment for evaluated patients.

Through CDA technology, AnPac Bio-Medical aims to address a number of goals, including:

  • Innovate – AnPac Bio-Medical is an innovator in the cancer screening industry, with CDA research ongoing since 2008, and commercial operations beginning in 2015. AnPac considers itself a thought leader in developing multi-cancer screening.
  • Detect – AnPac Bio-Medical detects early signals of threatening cancer and its location within the body.
  • Identify – CDA identifies the risks of up to 26 different types of cancers with high sensitivity and specificity rates.
  • Provide – The company’s platform provides multi-level, multi-parameter analysis using proprietary diagnostic algorithms, which results in accurate and easy-to-understand results.
  • Proven – A fully operational analysis of over 200,000 test samples has been run to date. CDA technology has been shown to identify pre- and early-stage cancers in patients previously diagnosed as “cancer-free” through traditional methods.
  • Biophysical Properties – CDA analyzes biophysical properties in human blood and the correlation between biophysical properties and cancer occurrence.

Market Outlook

AnPac Bio-Medical is exploring detection of other types of cancers leveraging its innovative CDA technology and multi-cancer screening and detection tests, which could open significant opportunities on the global cancer diagnostics market.

According to a report by Grand View Research, the cancer diagnostics market is expected to reach $249.6 billion worldwide by 2026 (https://nnw.fm/L7css). The market is expected to grow at a CAGR of 7% during the forecast period.

Management Team

Dr. Chris Yu is the Co-Founder and Chief Executive Officer of AnPac Bio-Medical. He has enjoyed a successful career as an innovator in life sciences, technology and engineering. Dr. Yu has worked for three U.S. Fortune 500 companies and is the first/principal inventor of over 300 patent applications spanning semiconductors, materials and life science. He has a proven history of developing cutting-edge products with long-term profit and sustainability. Dr. Yu was born to a medical doctor’s family and went to medical school. He later switched his major to physics and received his bachelor’s and master’s degrees in physics from the University of Missouri-Kansas City Campus and a doctoral degree in physics from Pennsylvania State University. Both of his dissertations addressed innovative detection techniques.

Dr. Herbert Yu is the Co-Founder and Chief Medical Officer of AnPac Bio-Medical. He is a renowned expert in molecular epidemiology, with training in medicine and chemical biochemistry. Dr. Yu has a 20-year career in leading-edge cancer research, including breakthrough work in areas of carcinogenic factors. He is a professor and research director at the University of Hawaii and an adjunct professor at Yale University. He received his bachelor’s degree in medicine from Shanghai First Medical College. Dr. Yu also received a science degree in epidemiology and a Ph.D. in clinical biochemistry from the University of Toronto.

Jingiu (Edward) Tang is the company’s Chief Financial Officer. He previously served as a global internal auditor at Natuzzi S.p.A. Mr. Tang also worked at Beijing Dongshen CPA and Shanghai De’an CPA, providing external audits, finance and tax advisory services across different industries and sectors. He is a Certified Public Accountant in Australia. Mr. Tang received his bachelor’s degree in accounting from Charles Sturt University in Australia, his MBA from Charles Sturt University, and his bachelor’s degree in law from Southwest University of Science and Technology in China.

Weidong Dai is the company’s China General Manager. He previously served as a general partner at Stirrfir Investment Management Co. Mr. Dai has also served as the chairman of RTS Management (Shanghai) Co., and as managing director of Hong Kong Pro-Health Technology Co. and Shanghai Pro-Health Medical Devices Co. He has published a number of medical research papers and research articles in professional journals. Mr. Dai was awarded the Hong Kong Industrial Award for a medical device that he led in research and development. He earned his bachelor’s degree in medicine from Anhui Medical University, a master’s degree in medicine from the Sun Yat-San University of Medicine, and an Advanced Certificate of the EMBA CEO Program from Fudan University, School of Economics.

AnPac Bio-Medical Science Co. Ltd. (ANPC), closed Wednesday's trading session at $1.21, up 1.6807%, on 364,847 volume with 817 trades. The average volume for the last 3 months is 365,647 and the stock's 52-week low/high is $1.01/$12.09.

Recent News

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC)

The QualityStocks Daily Newsletter would like to spotlight BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC).

  • Best Startup Canada named BevCanna Enterprises one of the 101 Top Food and Beverage Startups and Companies in Canada
  • BevCanna was also recognized as one of the Top 101 Cannabis Startups in the country
  • The company has had strong growth momentum in its core business, with 3Q21 revenues rising over 1,000% year-over-year
  • BevCanna signed an agreement to manufacture and white-label cannabis beverages on behalf of Averi Health Products, which will subsequently be distributed in the Canadian market

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) — a diversified health & wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients — announced that it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada, a media company that focuses on the latest innovations, breakthroughs and greatest companies across Canada (https://cnw.fm/51WJm). Ranging from cutting-edge startups to established brands within the food and beverage sector, the companies recognized on the prestigious Top 101 list are known for both their innovation within their field as well as their exceptional growth and social impact. The past couple of years have seen more than two dozen states pass some form of cannabis regulation, making marijuana more accessible to the public than ever. Customers are loving it — in just a few short years, consumers have purchased billions of dollars’ worth of legal cannabis. Based on the almost insane demand for cannabis, experts project that the industry will see significant growth in the future, achieving a valuation of $198 billion in 2028. Customers are especially attracted to cannabis due to its allegedly potent and versatile medical abilities. Younger generations have been drinking less and less alcohol, so it’s not surprising that these younger consumers would turn to cannabis. Not only does the substance have zero of the side effects alcohol consumption induces, but it also has some therapeutic benefits. Players such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) in the cannabis industry have been quick to notice this, developing a range of alcoholic and nonalcoholic cannabis-infused drinks to meet market demand for an alternative to alcohol.

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The BevCanna team boasts decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale.

BevCanna’s distribution network features more than 3,000 points of retail distribution through the company’s market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network and its partnership with #1 U.S. cannabis beverage company Keef Brands.

Based in British Columbia, Canada, BevCanna was founded in 2017.

End-to-End Turnkey Beverage Manufacturing Solutions

BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients, in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white label beverage manufacturing solution.

  • Processing – At its state-of-the-art beverage manufacturing facility, BevCanna partners with industry leaders specializing in crude extraction, refinement, purification and solubility conversion to provide high-quality water-immiscible emulsions that maximize bioavailability, clarity and taste.
  • Spring Water – BevCanna directly owns a pristine naturally alkaline spring water aquifer in British Columbia.
  • Product Development – BevCanna leverages its expertise to develop captivating flavors based on category and consumer insights in order to enhance product positioning.
  • Packaging – A variety of packaging options are offered by BevCanna, including beverage and nutraceutical formats such as PET, aluminum and glass, available in a variety of standard and custom sizes and shapes.
  • Beverage Manufacturing: Traditional & Cannabis Facilities – The company’s 40,000-square-foot beverage manufacturing facility is HACCP (Hazard Analysis Critical Control Point) Certified. The facility’s capabilities include blow molding, dosing, carbonation options, filling and capping, pressure sensitive and shrink-sleeve label applications, flash pasteurization, QA testing and packing/palletizing for shipment.

Pure Therapy, TRACE and Partner Brands

BevCanna’s in-house brands include Pure Therapy and TRACE.

Pure Therapy is a direct-to-consumer e-commerce brand that markets a range of natural health products, including nutraceuticals and hemp-based cannabidiol (CBD) products, throughout North America and Western Europe.

Pure Therapy has secured orders from over 23,000 customers since its inception in 2017. BevCanna expects strong growth through Pure Therapy over the next 12 months driven by new product integration, accelerated growth of existing products and its marketing team’s e-commerce expertise.

TRACE products feature the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels.

Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer a number of key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness.

TRACE products include Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D and Plant-Based Mineralized Immune Support Shots.

In addition to its in-house brands, BevCanna provides white-label services to a number of partners in its space. BevCanna’s current portfolio of brand partnerships includes #1 U.S. cannabis beverage brand Keef (cannabis-infused classic soda) and BLOOM (live resin & high-end extracts). BevCanna also has multiple white label agreements to co-manufacture branded beverages.

Market Outlook for Cannabis-Infused Beverages

In 2018, the cannabis-infused beverage market was valued at $901.8 million. The market is expected to grow during the forecast period of 2019 to 2025 at a CAGR of 17.8%, resulting in a market value in excess of $2.84 billion by 2025, according to Grand View Research (https://ibn.fm/VkJfH).

The projected growth is largely attributed to the legalization of recreational and medical marijuana in multiple jurisdictions. Cannabis-infused beverages are uniquely positioned to provide an alternative to a large portion of the edibles market, including items such as chocolates, cookies, gummies and other types of confectionery pieces.

Management Team

Marcello Leone is the CEO and Founder of BevCanna. He is also the founder of Naturo Group and the TRACE brand.

John Campbell is the CFO and CSO of BevCanna. He has over 30 years of experience in the investment industry, including time with TriView Capital Ltd.

Keith Dolo is the company’s Executive Management Advisor, having previously served as CEO and Executive Chairman of Sproutly Inc. Previously, he served for over 13 years with Robert Half (NYSE: RHI), an S&P 500 company, specifically in the role of Vice President for the last eight years.

Melise Panetta is the company’s President. She is an accomplished senior marketing and sales executive with extensive experience leading organizations such as SC Johnson, General Mills (NYSE: GIS) and PepsiCo (NASDAQ: PEP). Ms. Panetta has nearly 15 years of deep marketing and sales expertise.

Raffael Kapusty is the company’s Vice President of Sales & Insights. She is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. With a solid foundation at ACNielsen Canada (NYSE: NLSN), Ms. Kapusty has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kroger (NYSE: KR), SC Johnson and Unilever Canada (NYSE: UL).

Bill Niarchos is the company’s Vice President of Sales & Sales Operations. He has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Mr. Niarchos managed the strategic direction and growth of Loblaw & SDM. Prior to his position with Bayer (ETR: BAYN), Mr. Niarchos held a number of progressive roles at Colgate Palmolive (NYSE: CL) for more than 14 years.

Japheth Noah is the company’s Head of Quality Assurance. He is an Oxford and MIT educated quality and regulatory manager with over 15 years of experience in the beverage, pharmaceutical, natural health and medical industries.

Keith Stride is the company’s Creative Director. He has 25 years of experience in marketing and advertising, including time in a CMO role with Hemptown USA. Mr. Stride is internationally recognized for building high-profile brands, including Rogers (NYSE: RCI), TD Bank (NYSE: TD), Best Buy (NYSE: BBY), Whistler-Blackcomb and RBC (NYSE: RY).

BevCanna Enterprises Inc. (OTCQB: BVNNF), closed Wednesday's trading session at $0.1611, up 2.9393%, on 15,792 volume with 24 trades. The average volume for the last 3 months is 15,792 and the stock's 52-week low/high is $0.14/$1.20.

Recent News

Cannabis Strategic Ventures Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures Inc. (NUGS).

Businesses in the cannabis space have always faced the risk of burglaries and robberies. For starters, they sell a product that is in extremely high demand both on the legal and black markets. Secondly, marijuana’s classification as a Schedule I controlled drug has made it difficult for cannabis businesses to access banking services because most banks refuse to serve cannabis businesses. This forces them to transact on a cash-only basis, meaning cannabis businesses tend to have large amounts of cash on-site. Consequently, marijuana businesses present an attractive target to criminals looking to make a quick buck. Over the last couple of months, the rate of robberies in the cannabis sector has spiked. Businesses in San Francisco alone reported more than 25 break-ins, stolen property and millions of dollars in damage in the last two months. As such, a leading cannabis advocacy group is providing resources that will guide marijuana businesses on how they can mitigate and respond to instances of theft. Only federal reform would address many of the hurdles that licensed marijuana companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) face as they try to balance between adhering to enabling state laws while also being cognizant of the prohibitive stance of the federal government.

Cannabis Strategic Ventures Inc. (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator. The company is based in Los Angeles, with a 6-acre cannabis farm in Northern California called NUGS Farm North. The company’s vision is to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration.

Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the City of Los Angeles and the State of California, and it is now working toward taking operational control of each license. The company also recently announced the upcoming grand opening of its cannabis dispensary, MDRN Tree. Following that launch, Cannabis Strategic Ventures intends to deploy another of its new licenses to establish an indoor cultivation facility with capacity to produce two to three pounds of premium exotic cannabis flower per light per harvest. The facility will have up to 1,200 grow lights and is anticipated to yield 5.75 harvests per year, bringing it to a total production capacity of over 15,000 pounds of cannabis flower annually.

Brand Portfolio

The company owns multiple brands under the Cannabis Strategic Ventures umbrella. The firm’s NUGS brand provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands.

The NUGS Farm North brand operates as a six-and-a-half-acre cannabis cultivation property located in northern California. The company believes that the key to success in its business is consistent quality and reliable supply to fit growing consumer demand. Cannabis Strategic Ventures addressed these consumer needs by building NUGS Farm North. At NUGS Farm North, the company’s process is customized, and its product is consistent. Located in the heart of an agricultural mecca for globally distributed produce, NUGS Farm North finds power in its product, not in its size. Decades of agricultural experience and a dedication to consistency ensure quality cannabis.

MDRN Tree is Cannabis Strategic Ventures’ customer-facing dispensary brand. MDRN Tree will open its first Los Angeles location sometime in the fall of 2021. MDRN Tree will be the company’s factory retail store – a direct interface with the end-market community – where Cannabis Strategic Ventures plans on showcasing the cannabis flower produced at its NUGS Farm North cultivation site. This farm-to-sale model offers the potential to drive simultaneous gains in quality control and profitability.

Market Outlook

The demand for legal marijuana is expected to surge due to ongoing changes in U.S. state government policies toward cannabis. In addition, the number of indications for which medical marijuana is prescribed continues to increase steadily. These factors are expected to rapidly boost legal sales of cannabis products, opening new revenue channels for producers and retailers. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will only present more high growth opportunities for this market.

According to a report from Grand View Research, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a compound annual growth rate of 26.7 percent from 2021 to 2028. That CAGR would put the market value at roughly $30 billion as soon as 2025.

According to the report, “One of the major factors fueling market growth is the expanding demand for legal marijuana owing to the growing number of legal cannabis countries. (Due) to recent legalizations in different countries, the use of medical marijuana for various ailments is gaining momentum worldwide. Patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s, and many neurological disorders are administered medical marijuana. The demand for cannabis oil is increasing rapidly, especially among countries with legalized medical marijuana.”

Management Team

Simon Yu is CEO, President, CFO and Secretary of Cannabis Strategic Ventures. He is also a co-founder, former COO and board member of Clubhouse Media Group Inc., a publicly traded social media company. Mr. Yu holds an MBA from the University of Southern California.

Cannabis Strategic Ventures Inc. (NUGS), closed Wednesday's trading session at $0.0275, up 5.7692%, on 748,814 volume with 45 trades. The average volume for the last 3 months is 748,814 and the stock's 52-week low/high is $0.0201/$0.62.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

Friendable (OTC: FDBL), a mobile technology and marketing company, has announced the expansion of service offerings available on its Fan Pass Live artist platform; those services include different options for music distribution and indie artist tools. The announcement was made as the company provided an update on and timeline for key milestones and achievements reached in 2021. That timeline included release of the Fan Pass platform in April 2020 and ending with the announcement that FDBL had signed a material agreement in December 2021 outlining the acquisition of Artist Republik, which includes artists, music distribution technology and services alongside various other offerings to be added to Fan Pass Live. “This is an exciting time for our company and specifically our Fan Pass Live artist platform,” said Friendable CEO Robert A. Rositano Jr. in the press release. “We believe these most recent milestone achievements have validated our approach to becoming a true artist partner, listening, testing, supporting and executing on everything we set out to accomplish, one goal at a time, and now it’s time to monetize as we build scale. It feels like our offering has now caught up with the artists’ specific needs, requests and desires. We now have the credibility, making 2022 the perfect opportunity for scaling revenues, number of artists and fan subscribers on the platform. Stay tuned for some exciting service offering announcements as we expand into various channels of music distribution and discuss all there is to know about Artist Republik and our integration path.” To view the full press release, visit https://ibn.fm/n2a0d

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from Livestream.com. The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., Nettaxi.com and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Wednesday's trading session at $0.0036, up 17.0732%, on 26,110,274 volume with 128 trades. The average volume for the last 3 months is 26.11M and the stock's 52-week low/high is $0.0026/$0.0649.

Recent News

Sugarmade, Inc. (OTC: SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (OTC: SGMD).

  • Nug Avenue success provides healthy backdrop as SGMD looks ahead to opening new locations
  • In addition to adding members, Nug Avenue has added new cannabis delivery technology to its format
  • New delivery tech provides everything from route optimization to real-time delivery updates, saving time and money while producing higher customer satisfaction

Cannabis delivery continues to be a promising space in California — and around the country, for that matter— and the success of Sugarmade’s (OTC: SGMD) Nug Avenue firmly establishes the company as a leader in the growing sector (https://cnw.fm/DZscn). SGMD is leveraging the combination of Nug Avenue’s high performance and new delivery technology as it moves forward with expansion plans. 

Sugarmade, Inc. (OTC: SGMD) is a product and brand marketing company investing in operations and technologies with disruptive potential. The company is focused on collaborating with real people in real-time to identify the emerging desires and behaviors poised to unlock new opportunities and pathways for growth. Sugarmade seeks to redefine the marketplace by nurturing an innovative and compelling relationship between brand, botany and business – resulting in both undeniable consumer value and an intriguing cross-pollination of revenue sources.

The company’s core strategic plan is centered on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade intends to develop a full farm-to-door vertically integrated cannabis business.

Brand Portfolio

Sugarmade has investments in a number of subsidiaries with active operations in the California cannabis sector. These include:

  • NUG Avenue – Sugarmade owns a 70% stake in NUG Avenue, a cannabis delivery service based in Southern California providing hand-selected top-shelf products from Stiiizy, Kanha, PlugPlay and more.
  • BudCars – Sugarmade is an investor in cannabis delivery service of BudCars’ first operating location in Sacramento, California. BudCars is an online-shopping experience designed to provide new customers with an easy way to discover and order cannabis products within minutes.

Acquisition of Lemon Glow Company

On May 17, 2021, Sugarmade took a major step toward closing the loop on what its management team believes to be one of the most promising vertically integrated cannabis models in the thriving California market when it announced the signing of a definitive agreement for its acquisition of Lemon Glow Company Inc.

The Lemon Glow acquisition includes 640 acres of property, 32 of which have already been designated for outdoor cannabis cultivation. Per the company’s news release, the annual potential cultivation yield at the property is estimated to be approximately 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total.

Notably, Sugarmade also benefits from the acquisition in terms of team capital, as Lemon Glow executive team members will stay on and become the core management team at the cannabis cultivation site, granting the operation over 30 years of cannabis cultivation experience.

“The Lemon Glow team are tremendous additions to the Sugarmade team,” Jimmy Chan, CEO of Sugarmade, commented in announcing the definitive agreement. “They have vast experience and established skills, as well as intricate knowledge of the property and its local grow context. That’s an enormous added value proposition in this deal. We look forward to bringing them on board, ramping up operations at the property, and taking key steps toward delivering on the promise of Sugarmade’s farm-to-door vision.”

Market Opportunity

The California cannabis industry has continued to record tremendous growth since voters approved a measure to legalize recreational use of the plant in 2016. According to data from MJBizDaily, California’s legal market hit $4.4 billion in sales in 2020, up from $2.8 billion in 2019 and $1.4 billion in 2018.

Those figures highlight California’s status as the largest legal cannabis market in the world. With roughly 28 million residents over the age of 21, California is more than twice the combined size of the four states (Arizona, New Jersey, Montana and North Dakota) that legalized cannabis in 2020.

The COVID-19 pandemic was a key driver in the growth of cannabis delivery services throughout the state in 2020. One California cannabis delivery firm reported a 60% increase in new delivery customer sign-ups in the 30 days following the March 13, 2020, declaration of a national emergency. As a result of this boom, tech companies in cannabis ecommerce were able to dramatically increase their market share.
Sugarmade’s continued efforts to develop a farm-to-door vertically integrated cannabis business position it to capitalize on these trends as the California cannabis industry continues to expand moving forward.

Management

Jimmy Chan is the CEO of Sugarmade. He is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Sugarmade, Inc. (OTC: SGMD), closed Wednesday's trading session at $0.0011, up 22.2222%, on 245,428,150 volume with 295 trades. The average volume for the last 3 months is 245.428M and the stock's 52-week low/high is $0.0008/$0.02.

Recent News

RYAH Group Inc. (CSE: RYAH)

The QualityStocks Daily Newsletter would like to spotlight RYAH Group Inc. (CSE: RYAH).

RYAH Group (CSE: RYAH) is the leader in volume-control technology for plant-based medicine. The company supports cannabis research for the treatment of cancer “with innovative technology that collects, analyzes and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of prescription treatments in a safe, secure and seamless way,” reads a recent article. “RYAH’s current portfolio integrates IoT devices, medicine-carrying components and mobile applications to create an ecosystem that enables practitioners and patients to administer treatments, control volume, collect data and produce analytics that can power insights for research purposes. Current products in the pipeline include a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage, and a Smart Liquid Dispensing Pen in the prototype stage.” To view the full article, visit https://ibn.fm/cO5Po

RYAH Group Inc. (CSE: RYAH) is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through the company’s IoT dose-measuring devices and AI analytics, RYAH is reshaping understanding of the value of devices combined with data, to positively impact the future treatment of patients for various medical conditions.

The company is a leading developer of dose-measuring IoT devices connected with its turn-key platform designed to aggregate and correlate HIPPA-compliant data, suitable to all participants in the patient treatment cycle. The company also specializes in customized, fully integrated, mobile applications and APIs, specifically designed to meet the needs of clinics, clinical trials, government and university research centers, for experimentation and treatment validation – significantly reducing variations in patient-related trials. RYAH unlocks data in the complete therapeutic plant lifecycle – from seed to consumption.

Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed to capture anonymous patient dosing and feedback, combined with detailed strain analytics, enabling customized dosing regiments. The company has secured numerous partnerships across the globe, including establishing a footprint in the UK, USA, Australia and Canada, and it has closed several deals in the European Union, as well. The company’s Smart-Inhaler has been selected as the dose-measurement, dose-control and data analytics platform for a UK pain management study and one of the world’s most ambitious and largest clinical trials ever to be conducted in cannabis.

Product Portfolio

The company’s current portfolio incorporates an ecosystem of IoT products, each consisting of three elements: the device, the medicine-carrying component and the mobile application. The product line currently includes a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage and a Smart Liquid Dispensing Pen in the prototype stage.

RYAH Smart-Inhaler

The RYAH Inhaler is the first dry-herb inhaler that allows users to track and control how much is inhaled, providing consistent and predictable results. This inhaler connects with the RYAH Health App, which features stat-tracking and presets for temperatures and dosages, all of which can be customized to individual needs and doctor recommendations, as well as a post-session review mechanism that allows the collection of session data and feedback for further efficacy analysis for customized dosing capabilities.

RYAH’s proprietary stainless-steel cartridges for the inhaler use QR technology that contains lab testing and grower information pertaining to the specific strain, thereby mitigating elicit product use and enabling completely transparent remote medicinal analytics, from seed to consumption.

In addition, the RYAH Cartridges provide a unique closed-loop recurring revenue opportunity for the company, as the RYAH Inhaler only works with this type of proprietary cartridges that licensed partners fill with medicine. The partners benefit from all the back-end data, providing them access to consumption habits, statistics and other data on patient preferences.

RYAH Smart-Patch

The RYAH Smart Transdermal Patch is a lightweight, reusable, mobile-controlled patch used for site-specific therapies. The Patch is an Electronic Topical Delivery Patch system intended for recommendation and administration by pain relief professionals and physical and occupational therapists. The patch data and the heating element is completely IoT and controlled by RYAH’s proprietary smartphone applications, which allows scheduling and ‘boosting’ medicine release, on-demand.

RYAH Smart-Pen

The RYAH Pen is an app-controlled liquid dispenser designed to provide a precise mix of up to three medicine components to create an ‘entourage effect’, enabling customized, wide-spectrum recommendation opportunities by licensed clinicians. The Smart-Pen will feature cartridges that contain CBD, THC and other isolates such as flavonoids or vitamins, or other solutions. There is a built-in mechanism designed to control usage based on recommended dosing schedules.

RYAH MD

RYAH MD serves as a remote and interactive patient-doctor collaboration and dosing administration platform. Doctors can remotely set dosage amounts for their patients, creating digital prescriptions for the RYAH IoT devices and tracking patient usage in real-time. RYAH MD offers features that include real-time monitoring, appointment booking, doctor-patient video calls and science-based strain recommendations, as well as promoting a better understanding of the effects and benefits of those recommendations among patients. Information is gathered from all of the RYAH devices.

PotBot App

The PotBot App is a medical cannabis education mobile application that leverages patented AI technology to capture structured and unstructured data to assist patients in learning about various treatments in plant-medicine based on their efficacy goals. The PotBot App is currently one of the top-rated medical cannabis educational mobile applications on the Apple App Store in the United States, with over 300,000 downloads.

Through the combination of peer-reviewed and empirical data, the PotBot App provides detailed information on the targeted and tested cannabinoid levels and associated strains from cannabis patients. The result is personalized and driven by data to inform patients of potential product matches associated with similar ailments and efficacy goals.

Market Outlook

RYAH holds a unique position in the $100.3 billion medical plant market, with the potential to capture and capitalize on growth opportunities made available by both the IoT and Data Intelligence sectors.

In 2018, the global IoT market was valued at $212.1 billion, and it is expected to grow exponentially to $1.3 trillion by 2026, registering a CAGR of 25.68%, according to Verified Market Research (https://ibn.fm/XtkPZ).

Management Team

Dr. Boris Goldstein, Ph.D., is the founder and Chairman of RYAH Group. He is a seasoned entrepreneur, investment banker and venture capitalist. He started his career as the founder of Software House HT, which grew into a worldwide corporation with over 40 offices in 17 countries. Since then, Goldstein has founded and served on the boards of directors and advisory boards for numerous companies in Silicon Valley and Silicon Alley. Goldstein brings experience in fundamental research, investment and technology, authoring multiple patents and books.

Gregory Wagner, MBA, is Chief Executive Officer and Director of RYAH Group. He has over 20 years of experience in global financial markets and entrepreneurship. Wagner has held executive roles in the United States and London. He has co-founded and built several startups from the ground up. His current licensures and degrees include FINRA Series 7, 63, 24 and 55, as well as an MBA from Fordham University. Wagner received a Certification in Innovation and Strategy from Harvard University.

RYAH Group Inc. (CSE: RYAH), closed Wednesday's trading session at $0.045, even for the day, on 12,500 volume with 5 trades. The average volume for the last 3 months is 464,702 and the stock's 52-week low/high is $0.03/$0.20.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has released a shareholder letter. The letter, from president and CEO Eric A. Adams, provided INM shareholders with a company update, including a look at key milestones the company had reached, including the acquisition of BayMedica, which Adams said positioned InMed as a clear leader in rare cannabinoid manufacturing. Adams also noted that the company continued to make significant strides with its proprietary IntegraSyn(TM) program and is advancing its pharmaceutical programs, thanks in large part to the library of novel cannabinoid analogs developed by BayMedica. The company also initiated a phase 2 trial of its INM-755 program for the treatment of epidermolysis bullosa (“EB”) and remained focused on advancing its INM-088 program for the treatment of glaucoma toward human clinical trials. In addition, Adams noted that the company is evaluating promising new research the use of a rare cannabinoid as a potential treatment option for neurodegenerative diseases. Financially, INM funded operations through the completion of two financings. Adams also announced an upcoming webinar, slated for Thursday, Jan. 6, 2022, during which the company’s management team will discuss the increasing demand for rare cannabinoids as well as plans for 2022. “Following the acquisition of BayMedica, our primary and immediate focus is completing the integration of the two companies and expediting commercial activities,” said InMed president and CEO Eric A. Adams in the letter. “We look forward to launching several new nonintoxicating rare cannabinoids in early 2022, including CBDV and THCV, two high-demand products in the consumer health and wellness sector, and envisage significant revenue growth over the coming quarters. Our unparalleled capabilities and expertise in cannabinoid manufacturing positions us as a leader in this burgeoning segment of the industry and sets us apart from our competitors.” To view the webinar, visit https://ibn.fm/g9egQ. To view the full press release, visit https://ibn.fm/KJM6W

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.

Manufacturing

The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Wednesday's trading session at $1.33, off by 2.2059%, on 178,765 volume with 411 trades. The average volume for the last 3 months is 179,765 and the stock's 52-week low/high is $1.2545/$6.42.

Recent News

Growth Capital Acquisition Corp. (NASDAQ: GCAC)

The QualityStocks Daily Newsletter would like to spotlight Growth Capital Acquisition Corp. (NASDAQ: GCAC).

Growth Capital Acquisition Corp. (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on February 2, 2021, with $172.5 million in Trust, and Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT® lidar solutions, on August 5, 2021, announced their entry into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed ‘Cepton Inc.’ and is expected to be listed on the Nasdaq stock exchange under new ticker symbol ‘CPTN’.

The proposed business combination, which has been unanimously approved by the boards of directors of Cepton and Growth Capital, is expected to be completed early in the first quarter of 2022, subject to, among other things, approval by Growth Capital’s stockholders, satisfaction of the conditions stated in the definitive agreement and other customary closing conditions.

Cepton Technologies Inc. is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s proposed merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Growth Capital Acquisition Corp. (NASDAQ: GCAC), closed Wednesday's trading session at $9.92, off by 0.201207%, on 10,212 volume with 17 trades. The average volume for the last 3 months is 10,212 and the stock's 52-week low/high is $9.55/$9.99.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

LQwD Fintech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, today provided a corporate re-cap. The update noted several milestones since the company completed the acquisition of LQwD Financial Corp. in June 2021, creating the first publicly traded Lightning Network company. “I wanted to take a moment to re-cap what has been an active six months for LQwD since listing in June,” said CEO Shone Anstey in the news release. “The remarkable growth of the Lightning Network has validated LQwD's reason to be hyper-focused on Lightning, and I look forward to continuing to expand our business on this rapidly growing global payment network.” To view the full press release, visit https://ibn.fm/fMt5L

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Wednesday's trading session at $0.2813, off by 11.677%, on 41,717 volume with 11 trades. The average volume for the last 3 months is 41,717 and the stock's 52-week low/high is $0.25/$4.00.

Recent News

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF)

The QualityStocks Daily Newsletter would like to spotlight PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF).

  • PlantX Life Inc. is an e-commerce retailer devoted to not only selling plant products, but educating consumers about their effective use and wellness benefits
  • The company has developed a weekly podcast series, YouTube channel videos and an active blog to provide information about the plant-based ecosystem 
  • Global thought leaders concerned about climate change are signaling the role traditional meat production plays in concerns about the planet’s environment, ranging from methane production to deforestation issues
  • Concerns about effective food production and climate sustainability also point to the conflicts and wars that inevitably arise from national insecurity
  • Consumers who identify themselves as vegan or largely interested in plant-based products are a rapidly growing sector of the food market, creating a need for an information hub such as that developed by PlantX Life

When world political leaders and influencers gathered for The 2021 United Nations Climate Change Conference, more commonly referred to as COP26, in October and November, concerns about how to abandon fossil fuel technologies in favor of fuels with a less-polluting, climate-sustaining footprint captured media attention. But another significant emerging concern among many of the nations is food sustainability as the earth’s climate grows hotter. Plant-based lifestyle e-retailer PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is working to position itself at the forefront of efforts to adopt a plant-based, alternative protein-based lifestyle that not only promotes nutritional health, but overall well-being through connectivity to the earth’s natural resources and efforts to sustain them. And in keeping with Spence’s observations, plant-based living could help promote national security. PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently announced the expansion of its e-commerce platform to the United Kingdom. The new platform, www.PlantX.uk, will offer customers a similar experience as PlantX’s customers in Canada and the United States, introducing a wide selection of novel brands and products for the growing plant-based community in the United Kingdom. “The timely launch dovetails with emerging trends in the U.K.’s plant-based space. According to a study conducted by the London School of Hygiene & Tropical Medicine (‘LSHTM’) in collaboration with the University of Oxford, the proportion of U.K. people who reported eating plant-based alternative foods nearly doubled between 2008-2011 and 2017-2019 from 6.7% to 13.1%,” reads a recent article. The piece quotes PlantX CEO Lorne Rapkin on the strategic move as saying, “Introducing new plant-based options to additional growing market segments is a recipe for success. Having our e-commerce site operational in the U.K. is the next evolutionary step on our way to expanding across the globe, and we’re excited to serve this market segment.” To view the full article, visit https://ibn.fm/u9q2H

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes and more.

PlantX is a high-growth technology company focusing on consumer-packaged goods (“CPG”) for the plant-based opportunity. The PlantX platform aims to serve as the digital face of this community with its one-stop-shop for everything plant-based, including:

  • An easy-to-use e-commerce shopping experience featuring the following:
    • Plant-based grocery items (from all your pantry needs to vitamins, cosmetics and even pet food)
    • Meal delivery with recipes created by well-known plant-based chefs throughout the world
    • Plant shop – delivering a wide variety of affordable indoor houseplants to homes across Canada and the U.S.
    • Easy to follow plant-based recipes every week
    • Partnerships with restaurants, nutritionists, chefs and brands
    • A community of like-minded individuals
  • State-of-the-art flagship PlantX locations

Since first launching in February 2020, PlantX Life has offered various services available through its comprehensive platform. This online marketplace features over 10,000 items across diverse product categories such as pantry items, beverages, personal care, pet food and indoor plants. In addition, PlantX has collaborated with renowned chefs and nutritionists to create 20 unique and pre-made meals delivered to the comfort of your own home.

Headquartered in Vancouver, Canada, PlantX’s mission is to spearhead the plant-based movement, celebrate and promote health and wellbeing, raise plant-based awareness in a hyper-palatable world, connect with global consumers and forge a welcoming plant-based community.

The company currently reports 4 million stock options and 24 million warrants outstanding, with a total of 88,832,159 shares issued and outstanding and a total market cap of $89.9 million on January 18, 2021. PlantX has continued to catalyze its capital markets dynamics by applying to list its common shares on the Nasdaq Capital Market (“NASDAQ”). The company’s common shares are eligible for electronic clearing and settlement through The Depository Trust Company (“DTC”) in the United States.

Market Outlook

With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9%. Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020.

Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behavior change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular and is expected to achieve a market value of $19.92 billion by 2027, expanding at a CAGR of 12.8%.

PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries.

Digital Platform for the Plant-Based Community

The digital interface provided by PlantX spans a health and wellness initiative that offers thousands of plant-based products, meal delivery, indoor plants, recipes and a community space for those who are like-minded about plant-based products and healthy lifestyles. PlantX has been compared to Amazon, except with a focused tailored selection of plant-based offerings.

PlantX provides everything a consumer needs for plant-based living at the click of a button. With PlantX, customers can:

  • Shop
  • Find recipes
  • Read blogs
  • Join a community forum
  • Listen to podcasts
  • View cosmetics
  • Research vitamins
  • Purchase plant-based pet foods
  • Read corporate updates
  • Subscribe to an insightful newsletter

The company’s website was designed with a user-friendly interface that allows customers to visit the site and easily find what they need. Forums for communicating with a plant-based community make it easier to swap recipes or locate the best restaurants serving vegan and vegetarian-friendly cuisine.

PlantX Flagship Locations – British Columbia (Canada), San Diego (California), & the State of Israel

PlantX will link the e-commerce platform to flagship brick-and-mortar stores for a highly sensory customer experience. This is anticipated to drive corporate growth and global brand recognition.

These PlantX branded flagship locations will first launch in:

Customer engagement, education and creating a global plant-based community will be furthered through this initiative.

PlantX Restaurant Partnerships

With consumers becoming better informed and more health and environmentally conscious, a growing number of restaurants will start catering to the needs of customers who are vegan, vegetarian, have food-allergies (or specialized diets), or simply want to eat healthier.

PlantX proactively aims to support this change and help restaurants meet the needs of the plant-based community. Restaurants that want to increase revenue, drive traffic and make an impact can therefore partner with PlantX to better serve their customers by expanding and refining their menus.

Future Goals for PlantX Life

Having successfully completed all of the milestones that PlantX had set-out to achieve in the second half of 2020, PlantX strives to continue scaling through organic growth, strategic partnerships and accretive M&A opportunities. The upcoming plans from PlantX includes a global expansion strategy for distribution in North America, Europe and Israel.

Verticals launched in 2020 include:

  • New meals and programs by renowned chefs
  • Flagship PlantX locations
  • PlantX branded goods
  • United States meal delivery and LIV
  • Online peer-to-peer fitness

Management Team

Sean Dollinger, the Founder of PlantX Life Inc., has had a very active professional career that started when he was only 17. While still in college, he started a delivery service that soon became one of Canada’s largest delivery firms (before companies like Postmates and Uber Eats ever existed). In 2014, Mr. Dollinger founded Namaste Technologies, the largest international e-commerce distributor of vaporizers and accessories. He brought Namaste public and turned it into a $1.2 billion business in two years. After finding a plant-based diet himself, and seeing the massive benefits that it provided for him, he decided he wanted to find a way to give back to the community and focus on something he loves. PlantX Life was born from this desire and became his passion project. He truly walks the talk.

Julia Frank is the CEO of PlantX Life. She has an MBA in digital entrepreneurship, and, in her past roles, she set up renowned strategies for large corporations like BMW and Daimler in Germany. Beyond her professional business prowess, Ms. Frank finds tremendous joy in preparing delicious and nutritious plant-based meals and is the face of the company. She practices a healthy and active lifestyle that includes experiencing as many cultures as possible to add more knowledge of the industry at large. This globally inclusive perspective gives her the unique advantage of being able to see plant-based living from all angles.

Lorne Rapkin, CPA, CA, LPA, is the President and CFO of PlantX Life and is also a partner at Rapkin Wein LLP. He has experience with clients in almost every industry, including finance, professional services, real estate, automotive, media and manufacturing. Mr. Rapkin works very closely with investment and public firms, seeking to comply with IFRS accounting standards. His roles often require him to work with management on go-public transactions, acquisitions and mergers. His keen attention to detail is an asset to any client he works with, and PlantX is no exception.

Alex Hoffman is the company’s CMO and has spent the last 10 years in the creative field cultivating her passion for design and appreciation for beauty. This is apparent in all of the creative decisions and outcomes seen at PlantX. Her role within the company is to oversee all of the brand marketing activities, establish and execute key processes for rapid growth, and work closely with management to refine the brand’s message for key segments and emerging opportunities. She has a sharp vision for exactly what’s needed to convey the company’s core messages and principles to both the public and investors, and she is a visionary with respect to creative marketing ideas and concepts.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), closed Wednesday's trading session at $0.14878, off by 7.6474%, on 171,028 volume with 52 trades. The average volume for the last 3 months is 171,028 and the stock's 52-week low/high is $0.145072/$1.85.

Recent News

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF)

The QualityStocks Daily Newsletter would like to spotlight Mydecine Innovations Group Inc. (MYCOF).

  • Mydecine has partnered with Dr. Matthew Johnson and Johns Hopkins University for two upcoming trials for MYCO-001 – a psilocybin approach to smoking cessation
  • The company is positioned to fill a billion-dollar hole in the industry after the leading pharmaceutical Chantix was removed from the market due to cancer risks
  • Two previous psilocybin trials conducted by Dr. Johnson, show promising results for the use of psilocybin as a smoking cessation tool when paired with cognitive behavioral therapy (“CBT”)

Smoking remains among the leading public health concerns of the 21st century. The total number of tobacco-related deaths worldwide has reached six million, a figure expected to rise to eight million by 2030 (https://ibn.fm/RYhMD). Earlier this year, one of the leading smoking cessation tools prescribed by physicians, Chantix, was pulled off the market for its cancer risk, leaving a large hole in a fast-growing market rife with opportunity. Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a  biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, is in a good position to tap into the opportunities offered by this sector, which is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9% (https://ibn.fm/4ag0A). Patients with cancer have a high risk of suicidal ideation and suicide, in particular patients in the advanced stages. These individuals often experience a loss of meaning in life and existential distress, which isn’t easily remedied through the use of pharmacological treatments. However, a new study has found that psilocybin when used together with psychotherapy may alleviate suicidal ideation in patients with life-threatening cancers. The improvements observed in patient mental health were maintained months and even years after treatment had been administered. The study’s findings were reported in the “ACS Pharmacology & Translational Science” journal. There is a more psychedelic medicine development being done by sector actors such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF). The years ahead look promising with regard to the availability of novel treatments that are more effective against mental health disorders.

Mydecine Innovations Group Inc. (NEO: MYCO) (NASDAQ: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health disorders and addiction. Founded in 2020 on the guiding principle that there is a significant unmet need and lack of innovations in the mental health and therapeutic treatment environments, Mydecine is dedicated to efficiently developing innovative first- and second-generation novel therapeutics to treat PTSD, addiction and other mental health disorders.

Mydecine’s business model combines clinical trials and data outcome, technology and scientific and regulatory expertise with a focus on psychedelic therapy underpinned by novel molecules with differentiated therapeutic potential. By collaborating with some of the world’s foremost authorities connected by best practices, Mydecine aims to responsibly fast-track the development of new medicines across its platforms, ultimately changing the way we treat mental health disorders. The company seeks to bridge the gap between the needs of patients and what the mental health care system currently provides.

Mydecine Innovations Group is headquartered in Denver with international offices in Canada and Europe.

Research and Technology

The invention and development of novel psychedelic and non-psychedelic molecules for medical use is an important part of Mydecine’s research strategy. The company uses molecules found in nature as building blocks to create improved second-generation drugs. This portfolio of new drugs represents major improvements to existing natural products and synthetics, including enhanced safety, efficacy, stability and dosing, as well as reduced side effects.

The goal of creating these improved second-generation compounds is to enable safer, more effective treatments for patients, along with improved management of dosage and drug behavior for clinicians. Mydecine believes the multibillion-dollar market for mental health and addiction disorder medicines will soon be disrupted amid a resurgence of the study into psychedelics and data showing the immense benefits of these forms of medicine.

The company currently has four lead drug candidates which include various enhancements such as improved controllability, delivery mechanisms, safety, stability and shelf-life. The drug candidates are in clinical trials or in pre-trial stage as potential treatments to aid PTSD, substance abuse and smoking cessation.

Mindleap Health is a wholly owned subsidiary of Mydecine. The Mindleap platform is a virtual community that aims to foster the conscious and responsible adoption of psychedelic medicine into inner wellness. Users access the platform through the Mindleap app. Mindleap provides users with inner wellness resources to assist them in their daily mental-health journeys. The platform also seeks to support the conscious and trustworthy adoption of psychedelics into a widely accepted approach to mental health and inner wellness.

Market Outlook

The global smoking cessation market is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9 percent from 2018 to 2026. The market for psychedelic therapeutics is in its very early stages. Estimates of current market value and forecasts of expected value in future years are all over the map. Market forecasts range from $6.5 billion by 2030 with a CAGR of 15 percent, to more than $69 billion as soon as 2025, at a CAGR of 8.2 percent. What is clear is that interest in psychedelic therapeutic drugs is expanding rapidly.

Management Team

Joshua Bartch is Chief Executive Officer and Chairman of Mydecine Innovations Group. He is an experienced entrepreneur who co-founded AudioTranscriptionist.com and founded Denver-based dispensary Doctors Orders in 2009. He also founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Bartch co-founded Cannabase.io, the USA’s most significant and sophisticated legal cannabis wholesale platform.

Dr. Rakesh Jetly, OMM, CD, MD, FRCPC, is the Chief Medical Officer of Mydecine. He was formerly Chief of Psychiatry for the Canadian Armed Forces, retiring in 2021 with the rank of colonel after 31 years of service. He began his career as a general duty medical officer and flight surgeon and spent his final 20 years of service as a psychiatrist. He maintains academic appointments at Dalhousie University and The University of Ottawa. He is the inaugural CF Brigadier Jonathan C. Meakins CBE, RCMAC, Chair in Military Mental Health at the Royal Ottawa Hospital.

Robert Roscow is Chief Scientific Officer of Mydecine. As a geneticist, he has spent his academic and professional careers looking for valuable and unique medicinal molecules found in nature. His innovations were applied at Canopy Growth and ebbu, where he ran those companies’ genetics divisions. He has leveraged his expertise to maximize industrial production of cannabinoids in a pharmacological context, resulting in multiple patent filings.

Damon Michaels is Chief Operating Officer of Mydecine. He previously consulted for various hemp businesses through his company, Emerald Baron. Before that, he served as GM for ebbu, the leading multi-platform cannabinoid research and technology firm based in Colorado. He has held leading roles with multiple large brands throughout the cannabis vertical. He also developed a national snowboard brand.

Mydecine Innovations Group Inc. (MYCOF), closed Wednesday's trading session at $0.109, off by 2.852%, on 379,753 volume with 117 trades. The average volume for the last 3 months is 379,753 and the stock's 52-week low/high is $0.01/$2.20.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading